In vitro acoustic characterization of three phospholipid ultrasound contrast agents from 12 to 43 MHz.
about
Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US.Low-Energy Ultrasound Treatment Improves Regional Tumor Vessel Infarction by Retargeted Tissue Factor.Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts.On-chip preparation of nanoscale contrast agents towards high-resolution ultrasound imaging.Detection of related substances in polyene phosphatidyl choline extracted from soybean and in its commercial capsule by comprehensive supercritical fluid chromatography with mass spectrometry compared with HPLC with evaporative light scattering dete
P2860
In vitro acoustic characterization of three phospholipid ultrasound contrast agents from 12 to 43 MHz.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
In vitro acoustic characteriza ...... rast agents from 12 to 43 MHz.
@ast
In vitro acoustic characteriza ...... rast agents from 12 to 43 MHz.
@en
type
label
In vitro acoustic characteriza ...... rast agents from 12 to 43 MHz.
@ast
In vitro acoustic characteriza ...... rast agents from 12 to 43 MHz.
@en
prefLabel
In vitro acoustic characteriza ...... rast agents from 12 to 43 MHz.
@ast
In vitro acoustic characteriza ...... rast agents from 12 to 43 MHz.
@en
P2093
P2860
P1476
In vitro acoustic characteriza ...... trast agents from 12 to 43 MHz
@en
P2093
Carmel M Moran
Mairead B Butler
P2860
P304
P356
10.1016/J.ULTRASMEDBIO.2013.10.010
P577
2013-12-19T00:00:00Z